Senator continues strong support of women’s abilities to make their own decisions about their health and futures
WASHINGTON – Arizona senior Senator Kyrsten Sinema and a group of lawmakers from the U.S. House and Senate submitted an amicus brief – also known as a “Friend of the Court” brief – in the Alliance for Hippocratic Medicine v. FDA case supporting the U.S. Food and Drug Administration’s (FDA) approval of mifepristone, a drug used by women and their doctors to manage reproductive health care, including miscarriage care.
“A woman’s health care decisions should be made between her, her doctor, and her family. We’re continuing to protect Arizona women’s abilities to make their own decisions about their futures,” said Sinema.
The brief was submitted to the U.S. Court of Appeals for the Fifth Circuit and urged the court to maintain FDA’s approval of mifepristone.
Mifepristone is one of the two medications typically used in reproductive and miscarriage care, which has been FDA-approved and safely used for over 20 years. The recent ruling would block the FDA’s approval of mifepristone nationwide and potentially endanger the FDA’s authority to ensure the safety and efficacy of medications such as insulin or other treatments.
Sinema, along with Republican Senators Lisa Murkowski (Alaska) and Susan Collins (Maine) and Democratic Senator Tim Kaine (Va.), recently introduced the Reproductive Freedom For All Act – bipartisan legislation protecting women’s abilities to make their own health care decisions by enacting the core protections of Roe v. Wade and related Supreme Court cases into law.